Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
40 results
  1. pdfNLM Associate Fellowship Project Report: Enhancing 'safety' and 'case report' search filters applied in MEDLINE to ... 
    https://www.nlm.nih.gov/.../NortonPharmacovigilanceSearch2017.pdf
    ... MEDLINE to support PubMed/EMERALD Literature ‘Alerts’ for pharmacovigilance Candace Norton, NLM Associate Fellow 2016-2017 August ... Discussion...................................................................... ........................................................................ ......10 Acknowledgements ....................................................................... ... ...12 Norton 2017 Pharmacovigilance 2 Abstract Objective This project, “Enhancing 'safety' and ' ...
  2. Research Awards, 2004 - Present 
    https://www.nlm.nih.gov/ep/AwardsResearch.html
    ... Laboratory Gonzalez Hernandez, Graciela Social Media Mining for Pharmacovigilance 2 R01 LM011176-06A1 University of Pennsylvania Hoen, ... Rbhs -cancer Institute of New Jersey Friedman, Carol Pharmacovigilance Methods: Leveraging Heterogeneous Adverse Drug Reaction Data 4 ...
  3. pdf2012 NLM Training Conference 
    https://www.nlm.nih.gov/.../TC2012TrainingConferenceBook.pdf
    ... Analysis of Drug Induced Gene Expression (Fernald - Stanford) • Pharmacovigilance and Drug Repurposing Model and Application: A Case ... Accounting for Sparse Data in the Training Set Pharmacovigilance and Drug Repurposing Model and Application: A Case ...
  4. NLM Informatics Training Conference 2012 
    https://www.nlm.nih.gov/ep/trainingconf2012.html
    ... Presentation June 26, 2012 Krystl Haerian Columbia University Pharmacovigilance and Drug Repurposing Model and Application: A Case ... 1 Abstract: An important component of drug safety, pharmacovigilance, entails detecting the risk of unknown serious adverse ...
  5. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... Reporting Systems Clinical Trials, Phase IV as Topic Pharmacovigilance Program Evaluation Reproducibility of Results Dimensional Measurement Accuracy ...
  6. pdf2016MeshTree.pdf 
    https://www.nlm.nih.gov/mesh/2016/download/2016MeshTree.pdf
    ... Phase IV as Topic E05.337.800.600...........................................Pharmacovigilance E05.337.820...........................................Program Evaluation E05.337.851........................................... ...
  7. NCBI's Open Data – A Source of Experimental Data for Important Discoveries - NCBI Insights 
    https://ncbiinsights.ncbi.nlm.nih.gov/...a-for-important-discoveries
    ... BioAssay study data and PubChem Compound’s annotations with pharmacovigilance data from the Canadian Adverse Drug Reaction database ... to look out for during clinical trials and pharmacovigilance studies, and should be used to promote awareness ...
  8. pdfNational Library of Medicine Programs and Services FY2013 
    https://www.nlm.nih.gov/ocpl/anreports/fy2013.pdf
    ... Using Biomedical Knowledge to Identify Plausible Signals for Pharmacovigilance 1 R01 LM011563-01A1 University of Texas Health ... Sciences - Cancer Institute of New Jersey FRIEDMAN, CAROL Pharmacovigilance Methods: Leveraging Heterogeneous Adverse Drug Reaction Data 2 ...
  9. Congressional Justification FY2013 
    https://www.nlm.nih.gov/about/2013CJ.html
    ... stress disorder patients), detection of adverse events, and pharmacovigilance. NLM's work will aim to develop modular software ... as health literacy, genome and the environment, and pharmacovigilance. NLM will continue to accept investigator-initiated grants ...
  10. pdfNLM FY 2011 CJ 
    https://www.nlm.nih.gov/about/2013CJ_NLM.pdf
    ... stress disorder patients), detection of adverse events, and pharmacovigilance. NLM’s work will aim to develop modular software ... as health literacy, genome and the environment, and pharmacovigilance. NLM will continue to accept investigator-initiated grants ...
first · previous · 1 · 2 · 3 · 4 · next · last